MetaCap

Co-Diagnostics (CODX) vs NexGel (NXGL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

NexGel is the larger company by market cap ($1.7 million vs $1.4 million), about 1.2 times the size. NexGel converts more of its revenue into profit, with a net margin of -26.3% versus -7533.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CODX-88.44%NXGL+1661.29%
+3336%+1542%-252%
Oct 7, 20261 yearNov 20, 2026
CODX-88.44%NXGL+1458.16%
+2830%+1301%-227%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CODX versus NXGL key metrics
MetricCODXNXGL
Share price$0.1295$3.12
Market cap$1.36M$1.67M
1-day change-21.32%-6.84%
EPS (TTM)$-21.71$-15.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$622.49K$11.42M
Revenue growth (YoY)-84.10%+31.46%
Net income (latest FY)$-46.90M$-3.00M
Gross margin64.28%39.48%
Operating margin-8058.83%-29.35%
Net margin-7533.62%-26.27%
52-week high$13.54$40.40
52-week low$0.1276$3.00
Distance from 52-week high-99.04%-92.27%
Analyst consensusnonehold
Avg. price target upside+2988.80%—
Average volume2.03M112.24K
Shares outstanding10.51M536.11K
Employees11519
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NexGel is more profitable, keeping -26.3 cents of every revenue dollar as net income versus -7533.6 cents for Co-Diagnostics.
  • NexGel grew revenue faster in its latest fiscal year (+31.46% vs -84.10%).

About Co-Diagnostics

CODX stock →

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Health Care · Medical/Dental Instruments · 115 employees

About NexGel

NXGL stock →

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

Health Care · Medical/Dental Instruments · 19 employees

CODX vs NXGL FAQ

Which is bigger, Co-Diagnostics or NexGel?

NexGel (NXGL) is larger, with a market capitalization of $1.67M compared with $1.36M for Co-Diagnostics (CODX).

Are Co-Diagnostics and NexGel in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons